Gelteq Ltd (GELS)
About Gelteq Ltd
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $5.3M
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.3M
- Shares outstanding
- 7.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 29, 2024
Gelteq Ltd (GELS) Stock Price
- Trading 64% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Gelteq Ltd.
Write a review
News about Gelteq Ltd
News & sentiment via Polygon.io
Gelteq Ltd: frequently asked questions
Is Gelteq Ltd an American company?
Gelteq Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Gelteq Ltd publicly traded?
Yes — Gelteq Ltd is a publicly traded company. Its stock trades under the ticker symbol GELS on the NASDAQ.
What does Gelteq Ltd do?
Gelteq Ltd is an American Pharmaceuticals company in the Health & Beauty sector.
